vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and OCEANEERING INTERNATIONAL INC (OII). Click either name above to swap in a different company.
OCEANEERING INTERNATIONAL INC is the larger business by last-quarter revenue ($692.4M vs $493.8M, roughly 1.4× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 5.2%, a 1.6% gap on every dollar of revenue. On growth, OCEANEERING INTERNATIONAL INC posted the faster year-over-year revenue change (2.7% vs -1.7%). Over the past eight quarters, OCEANEERING INTERNATIONAL INC's revenue compounded faster (1.8% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Oceaneering International, Inc. is a subsea engineering and applied technology company based in Houston, Texas, U.S. that provides engineered services and hardware to customers who operate in marine, space, and other environments.
MD vs OII — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $692.4M |
| Net Profit | $33.7M | $36.1M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | — |
| Net Margin | 6.8% | 5.2% |
| Revenue YoY | -1.7% | 2.7% |
| Net Profit YoY | 10.5% | -79.7% |
| EPS (diluted) | $0.40 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $692.4M | ||
| Q4 25 | $493.8M | $668.6M | ||
| Q3 25 | $492.9M | $742.9M | ||
| Q2 25 | $468.8M | $698.2M | ||
| Q1 25 | $458.4M | $674.5M | ||
| Q4 24 | $502.4M | $713.5M | ||
| Q3 24 | $511.2M | $679.8M | ||
| Q2 24 | $504.3M | $668.8M |
| Q1 26 | — | $36.1M | ||
| Q4 25 | $33.7M | $177.7M | ||
| Q3 25 | $71.7M | $71.3M | ||
| Q2 25 | $39.3M | $54.4M | ||
| Q1 25 | $20.7M | $50.4M | ||
| Q4 24 | $30.5M | $56.1M | ||
| Q3 24 | $19.4M | $41.2M | ||
| Q2 24 | $-153.0M | $35.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 19.8% | ||
| Q3 25 | — | 20.6% | ||
| Q2 25 | — | 21.3% | ||
| Q1 25 | — | 20.0% | ||
| Q4 24 | — | 19.9% | ||
| Q3 24 | — | 19.3% | ||
| Q2 24 | — | 18.0% |
| Q1 26 | — | — | ||
| Q4 25 | 9.9% | 9.8% | ||
| Q3 25 | 13.8% | 11.6% | ||
| Q2 25 | 12.8% | 11.3% | ||
| Q1 25 | 7.0% | 10.9% | ||
| Q4 24 | 7.8% | 10.9% | ||
| Q3 24 | 6.6% | 10.5% | ||
| Q2 24 | -31.3% | 9.0% |
| Q1 26 | — | 5.2% | ||
| Q4 25 | 6.8% | 26.6% | ||
| Q3 25 | 14.5% | 9.6% | ||
| Q2 25 | 8.4% | 7.8% | ||
| Q1 25 | 4.5% | 7.5% | ||
| Q4 24 | 6.1% | 7.9% | ||
| Q3 24 | 3.8% | 6.1% | ||
| Q2 24 | -30.3% | 5.2% |
| Q1 26 | — | $0.36 | ||
| Q4 25 | $0.40 | $1.75 | ||
| Q3 25 | $0.84 | $0.71 | ||
| Q2 25 | $0.46 | $0.54 | ||
| Q1 25 | $0.24 | $0.49 | ||
| Q4 24 | $0.37 | $0.55 | ||
| Q3 24 | $0.23 | $0.40 | ||
| Q2 24 | $-1.84 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | — |
| Total DebtLower is stronger | $570.5M | $488.8M |
| Stockholders' EquityBook value | $865.9M | $1.1B |
| Total Assets | $2.2B | $2.6B |
| Debt / EquityLower = less leverage | 0.66× | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $375.2M | $695.9M | ||
| Q3 25 | $340.1M | $7.0M | ||
| Q2 25 | $224.7M | $7.0M | ||
| Q1 25 | $99.0M | $7.0M | ||
| Q4 24 | $229.9M | $504.5M | ||
| Q3 24 | $103.8M | — | ||
| Q2 24 | $19.4M | — |
| Q1 26 | — | $488.8M | ||
| Q4 25 | $570.5M | $487.4M | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | $482.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $865.9M | $1.1B | ||
| Q3 25 | $890.7M | $907.7M | ||
| Q2 25 | $833.8M | $842.1M | ||
| Q1 25 | $789.2M | $773.1M | ||
| Q4 24 | $764.9M | $714.3M | ||
| Q3 24 | $732.5M | $698.0M | ||
| Q2 24 | $706.5M | $651.0M |
| Q1 26 | — | $2.6B | ||
| Q4 25 | $2.2B | $2.7B | ||
| Q3 25 | $2.2B | $2.5B | ||
| Q2 25 | $2.1B | $2.3B | ||
| Q1 25 | $2.0B | $2.3B | ||
| Q4 24 | $2.2B | $2.3B | ||
| Q3 24 | $2.1B | $2.4B | ||
| Q2 24 | $2.0B | $2.3B |
| Q1 26 | — | 0.44× | ||
| Q4 25 | 0.66× | 0.46× | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | 0.67× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | — |
| Free Cash FlowOCF − Capex | — | $-76.5M |
| FCF MarginFCF / Revenue | — | -11.1% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $238.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $114.1M | $221.1M | ||
| Q3 25 | $137.3M | $101.3M | ||
| Q2 25 | $137.2M | $77.2M | ||
| Q1 25 | $-117.5M | $-80.7M | ||
| Q4 24 | $133.0M | $128.4M | ||
| Q3 24 | $91.8M | $91.9M | ||
| Q2 24 | $107.0M | $52.6M |
| Q1 26 | — | $-76.5M | ||
| Q4 25 | — | $190.7M | ||
| Q3 25 | — | $77.0M | ||
| Q2 25 | — | $46.9M | ||
| Q1 25 | — | $-106.8M | ||
| Q4 24 | — | $94.5M | ||
| Q3 24 | — | $67.0M | ||
| Q2 24 | — | $29.8M |
| Q1 26 | — | -11.1% | ||
| Q4 25 | — | 28.5% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | 6.7% | ||
| Q1 25 | — | -15.8% | ||
| Q4 24 | — | 13.2% | ||
| Q3 24 | — | 9.9% | ||
| Q2 24 | — | 4.5% |
| Q1 26 | — | 2.5% | ||
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 3.3% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | 4.7% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 3.4% |
| Q1 26 | — | — | ||
| Q4 25 | 3.39× | 1.24× | ||
| Q3 25 | 1.91× | 1.42× | ||
| Q2 25 | 3.49× | 1.42× | ||
| Q1 25 | -5.66× | -1.60× | ||
| Q4 24 | 4.36× | 2.29× | ||
| Q3 24 | 4.72× | 2.23× | ||
| Q2 24 | — | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
OII
| Backlog at end of period | $492.0M | 71% |
| Other | $162.8M | 24% |
| ROV days available | $22.5M | 3% |
| ROV days utilized | $15.1M | 2% |
